Adrenal incidentaloma: Differential diagnosis and management strategies

Valentina Morelli, Serena Palmieri

Research output: Contribution to journalReview article

Abstract

Adrenal incidentaloma is a frequent clinical finding. Once an adrenal mass is detected, is mandatory to determine whether the lesion is malignant or benign and whether it is hormonally active or non-functioning, to estabilish an adequate treatement or follow-up. The European Society of Endocrinology and ENSAT Guideline recently provided the best recommendation based on the available literature. However, due to the retrospective design of the majority of the studies, the small number of patients included and the inadequate follow-up, some issues are still unresolved. In particular, there is a general consensus about the need of adrenalectomy in the presence of unilateral adrenal mass and clinically relevant hormone excess or radiological findings suspected for malignancy. On the other side, how to manage adrenal masses with indeterminate characteristics or subtle cortisol secretion, and how long the radiological and functional follow-up of benign adrenal mass should last in non-operated patients, are still open questions. Therefore, high-quality research for establish the adequate management of these patients and randomized clinical trials are needed to avoid unnecessary investigations and invasive procedures and ensure a clinically effective work-up.

Original languageEnglish
Pages (from-to)4-18
Number of pages15
JournalMinerva Endocrinologica
Volume44
Issue number1
DOIs
Publication statusPublished - Mar 1 2019

Fingerprint

Differential Diagnosis
Adrenalectomy
Hydrocortisone
Randomized Controlled Trials
Hormones
Guidelines
Research
Adrenal incidentaloma
Neoplasms

Keywords

  • Adrenal incidentaloma
  • Adrenocortical hyperfunction
  • Hydrocortisone.

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Cite this

Adrenal incidentaloma : Differential diagnosis and management strategies. / Morelli, Valentina; Palmieri, Serena.

In: Minerva Endocrinologica, Vol. 44, No. 1, 01.03.2019, p. 4-18.

Research output: Contribution to journalReview article

@article{cefcd557257b49eaaa50d2d19b3bb3f2,
title = "Adrenal incidentaloma: Differential diagnosis and management strategies",
abstract = "Adrenal incidentaloma is a frequent clinical finding. Once an adrenal mass is detected, is mandatory to determine whether the lesion is malignant or benign and whether it is hormonally active or non-functioning, to estabilish an adequate treatement or follow-up. The European Society of Endocrinology and ENSAT Guideline recently provided the best recommendation based on the available literature. However, due to the retrospective design of the majority of the studies, the small number of patients included and the inadequate follow-up, some issues are still unresolved. In particular, there is a general consensus about the need of adrenalectomy in the presence of unilateral adrenal mass and clinically relevant hormone excess or radiological findings suspected for malignancy. On the other side, how to manage adrenal masses with indeterminate characteristics or subtle cortisol secretion, and how long the radiological and functional follow-up of benign adrenal mass should last in non-operated patients, are still open questions. Therefore, high-quality research for establish the adequate management of these patients and randomized clinical trials are needed to avoid unnecessary investigations and invasive procedures and ensure a clinically effective work-up.",
keywords = "Adrenal incidentaloma, Adrenocortical hyperfunction, Hydrocortisone.",
author = "Valentina Morelli and Serena Palmieri",
year = "2019",
month = "3",
day = "1",
doi = "10.23736/S0391-1977.18.02868-7",
language = "English",
volume = "44",
pages = "4--18",
journal = "Minerva Endocrinologica",
issn = "0391-1977",
publisher = "Edizioni Minerva Medica S.p.A.",
number = "1",

}

TY - JOUR

T1 - Adrenal incidentaloma

T2 - Differential diagnosis and management strategies

AU - Morelli, Valentina

AU - Palmieri, Serena

PY - 2019/3/1

Y1 - 2019/3/1

N2 - Adrenal incidentaloma is a frequent clinical finding. Once an adrenal mass is detected, is mandatory to determine whether the lesion is malignant or benign and whether it is hormonally active or non-functioning, to estabilish an adequate treatement or follow-up. The European Society of Endocrinology and ENSAT Guideline recently provided the best recommendation based on the available literature. However, due to the retrospective design of the majority of the studies, the small number of patients included and the inadequate follow-up, some issues are still unresolved. In particular, there is a general consensus about the need of adrenalectomy in the presence of unilateral adrenal mass and clinically relevant hormone excess or radiological findings suspected for malignancy. On the other side, how to manage adrenal masses with indeterminate characteristics or subtle cortisol secretion, and how long the radiological and functional follow-up of benign adrenal mass should last in non-operated patients, are still open questions. Therefore, high-quality research for establish the adequate management of these patients and randomized clinical trials are needed to avoid unnecessary investigations and invasive procedures and ensure a clinically effective work-up.

AB - Adrenal incidentaloma is a frequent clinical finding. Once an adrenal mass is detected, is mandatory to determine whether the lesion is malignant or benign and whether it is hormonally active or non-functioning, to estabilish an adequate treatement or follow-up. The European Society of Endocrinology and ENSAT Guideline recently provided the best recommendation based on the available literature. However, due to the retrospective design of the majority of the studies, the small number of patients included and the inadequate follow-up, some issues are still unresolved. In particular, there is a general consensus about the need of adrenalectomy in the presence of unilateral adrenal mass and clinically relevant hormone excess or radiological findings suspected for malignancy. On the other side, how to manage adrenal masses with indeterminate characteristics or subtle cortisol secretion, and how long the radiological and functional follow-up of benign adrenal mass should last in non-operated patients, are still open questions. Therefore, high-quality research for establish the adequate management of these patients and randomized clinical trials are needed to avoid unnecessary investigations and invasive procedures and ensure a clinically effective work-up.

KW - Adrenal incidentaloma

KW - Adrenocortical hyperfunction

KW - Hydrocortisone.

UR - http://www.scopus.com/inward/record.url?scp=85058751178&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85058751178&partnerID=8YFLogxK

U2 - 10.23736/S0391-1977.18.02868-7

DO - 10.23736/S0391-1977.18.02868-7

M3 - Review article

C2 - 29808642

AN - SCOPUS:85058751178

VL - 44

SP - 4

EP - 18

JO - Minerva Endocrinologica

JF - Minerva Endocrinologica

SN - 0391-1977

IS - 1

ER -